<--- Back to Details
First PageDocument Content
Medicine / Clinical medicine / Immunology / RTT / Autoimmune diseases / Immunosuppressants / Rheumatology / Arthritis / Disease-modifying antirheumatic drug / Infliximab / Methotrexate / Psoriatic arthritis
Date: 2016-06-15 11:10:11
Medicine
Clinical medicine
Immunology
RTT
Autoimmune diseases
Immunosuppressants
Rheumatology
Arthritis
Disease-modifying antirheumatic drug
Infliximab
Methotrexate
Psoriatic arthritis

Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8Toll Free on PEI) Programmes provinciaux de médicaments

Add to Reading List

Source URL: www.gov.pe.ca

Download Document from Source Website

File Size: 118,81 KB

Share Document on Facebook

Similar Documents

Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8Toll Free on PEI)  Programmes provinciaux de médicaments

Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8Toll Free on PEI) Programmes provinciaux de médicaments

DocID: 1qAvE - View Document

TABLE OF CONTENTS  INTRODUCTION 2

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1qius - View Document

THE EFFECTIVENESS OF NON BIOLOGIC DMARDS AFTER ANTI TNF α INHIBITOR FAILURE DECISION SUPPORT UNIT Allan Wailoo, Jonathan Tosh School of Health and Related Research, University of Sheffield

THE EFFECTIVENESS OF NON BIOLOGIC DMARDS AFTER ANTI TNF α INHIBITOR FAILURE DECISION SUPPORT UNIT Allan Wailoo, Jonathan Tosh School of Health and Related Research, University of Sheffield

DocID: 1pY4l - View Document

TABLE OF CONTENTS  INTRODUCTION 2

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1pESm - View Document

TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

DocID: 1pnYX - View Document